0001144204-15-066896.txt : 20151119 0001144204-15-066896.hdr.sgml : 20151119 20151119124021 ACCESSION NUMBER: 0001144204-15-066896 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151116 FILED AS OF DATE: 20151119 DATE AS OF CHANGE: 20151119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIESTEK MAREK CENTRAL INDEX KEY: 0001658857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 151243093 MAIL ADDRESS: STREET 1: 108-20 71ST AVE, APT PH2C CITY: FOREST HILLS STATE: NY ZIP: 11375 4 1 v425155_4.xml OWNERSHIP DOCUMENT X0306 4 2015-11-16 0 0001293310 KALOBIOS PHARMACEUTICALS INC KBIO 0001658857 BIESTEK MAREK 108-20 71ST AVE, APT PH2C FOREST HILLS NY 11375 0 0 0 1 See Remarks Common Stock 2015-11-16 4 P 0 65000 1.36 A 65000 D Common Stock 2015-11-17 4 P 0 135000 1.83 A 200000 D The price reported in Column 4 is a weighted average price. Marek Biestek purchased 65,000 shares in multiple transactions at prices ranging from $0.82 to $1.66, inclusive. The reporting person undertakes to provide to Kalobios Pharmaceuticals, Inc., any security holder of Kalobios Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. The securities reported herein are owned directly by Marek Biestek, who is a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934. Marek Biestek individually owns less than 10%. There is no voting or ownership agreement amongst the group members and the other members of the group do not have a pecuniary interest in the shares reported herein. Correspondingly, Mr. Biestek does not have a pecuniary interest in the shares owned by the other members of the group. The price reported in Column 4 is a weighted average price. Marek Biestek purchased 135,000 shares in multiple transactions at prices ranging from $1.48 to $2.29, inclusive. The reporting person undertakes to provide to Kalobios Pharmaceuticals, Inc., any security holder of Kalobios Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4. Marek Biestek is a member of a "group" for purposes of Section 13(d) of the Exchange Act of 1934, but individually owns less than 10%. /s/ Marek Biestek 2015-11-18